Journal Of Personalized Medicine

雜志介紹

Journal Of Personalized Medicine雜志介紹

《Journal Of Personalized Medicine》是一本以English為主的開放獲取國際優秀期刊，中文名稱個性化醫學雜志，本刊主要出版、報道醫學-MEDICINE, GENERAL & INTERNAL領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為3，最新CiteScore 指數為4.1。

本刊近期中國學者發表的論文主要有：

• The Prognostic Value of the GNRI in Patients with Stomach Cancer Undergoing Surgery

  Author: Zhang, Qianqian; Zhang, Lilong; Jin, Qi; He, Yongheng; Wu, Mingsheng; Peng, Hongxing; Li, Yijin

• Comparison of Pedicled Adductor Longus and Pedicled Sartorius Flap in Inguinal Reconstruction, a Fresh Cadaver Study

  Author: Zhang, Hong; Li, Zhenfeng; Li, Jianmin; Zhu, Binghong; Xu, Qingjia

• Predicting Tumor Mutation Burden and EGFR Mutation Using Clinical and Radiomic Features in Patients with Malignant Pulmonary Nodules

  Author: Yin, Wenda; Wang, Wei; Zou, Chong; Li, Ming; Chen, Hao; Meng, Fanchen; Dong, Guozhang; Wang, Jie; Yu, Qian; Sun, Mengting; Xu, Lin; Lv, Yang; Wang, Xiaoxiao; Yin, Rong

• Bone Metastasis in Bladder Cancer

  Author: Yi, Lei; Ai, Kai; Li, Xurui; Li, Zhihong; Li, Yuan

英文介紹

Journal Of Personalized Medicine雜志英文介紹

Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. JPM publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., pharmacogenomics/proteomics, systems biology). JPM recognizes that personalized medicine—the assessment of genetic, environmental and host factors that cause variability of individuals—is a challenging, transdisciplinary topic that requires discussions from a range of experts. For a comprehensive perspective of personalized medicine, JPM aims to integrate expertise from the molecular and translational sciences, therapeutics and diagnostics, as well as discussions of regulatory, social, ethical and policy aspects. We provide a forum to bring together academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities.